Large and round tumor nuclei in osteosarcoma: Good clinical outcome

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 2, 2011, Pages 169-174

  de Andrea, Carlos E ^a   Petrilli, Antonio Sergio ^a   Jesus Garcia, Reynaldo ^a   Bleggi Torres, Luiz F ^b,c   Alves, Maria Teresa S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

Author keywords

Large nuclei; Nuclear morphometry; Osteosarcoma; Round nuclei

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; BRAZIL; CELL NUCLEUS; CHILD; FEMALE; HUMAN; IMAGE PROCESSING; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; METASTASIS; MORTALITY; NUCLEAR SHAPE; OSTEOSARCOMA; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; BONE NEOPLASMS; BRAZIL; CELL NUCLEUS; CELL NUCLEUS SHAPE; CHILD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; OSTEOSARCOMA; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 79958704998     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002.
2. Unni KK. Osteosarcoma of bone. J Orthop Sci 1998;3:287-94.
3. Bramer JA, van Linge JH, Grimer RJ, Scholten RJ. Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol 2009;35:1030-6.
4. Dahlin DC, Unni KK. Bone tumors. General aspects and data on 8,542 cases. 4 ed. Springfield, Illinois: C.C. Thomas Publ.; 1986.
5. Ishida T, Kikuchi F, Machinami R. Histological grading and morphometric analysis of cartilaginous tumours. Virchows Arch A Pathol Anat Histopathol 1991;418:149-55.
6. Kazanowska B, Jelen M, Reich A, Tarnawski W, Chybicka A. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children. Histopathology 2004;45:352-9.
7. Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J Urol 1982;128:729-34.
8. Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW. Prediction of prostatespecific antigen recurrence in men with longterm follow-up postprostatectomy using quantitative nuclear morphometry. Cancer Epidemiol Biomarkers Prev 2008;17:102-10.
9. Bol MG, Baak JP, Rep S, et al. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder. Urology 2002;60:1124-30.
10. Carducci MA, Piantadosi S, Pound CR, Marx WL, Kruse AJ, Bos SD, Kisman O, Voorhorst FJ. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology 1999;53:44-9.
11. De Andrea CE, Bleggi-Torres LF, Alves MTS. Nuclear morphometric analysis: description of the methodology and the role of image-editing softwares. J Bras Patol Med Lab 2008;44:51-7.
12. Benites EC, Paiva MG, Cappellano AM. Clinical, serum cardiac troponin T and echocardiographic evaluation for prediction of late doxorubicin cardiotoxicity. J Clin Oncol [abstract] 2006;24(18S):9536.
13. Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002;38:1218-25.
14. Yamamoto T, Marui T, Mizuno K, Kizaki T, Minami R, Hanioka K, Hayashi Y. Anaplastic osteosarcoma with abundant eosinophilic cytoplasm and minimal osteoid production. Pathol Int 2000;50:553-7.
15. Ayala AG, Ro JY, Raymond AK, Jaffe N, Chawla S, Carrasco H, Link M, Jimenez J, Edeiken J, Wallace S. Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer 1989;64:2162-73.
16. Apel R, Delling G, Krumme H, Winkler K, Salzer-Kuntschik M. Nuclear polymorphism in osteosarcomas as a prognostic factor for the effect of chemotherapy. A quantitative study. Virchows Arch A Pathol Anat Histopathol 1985;405:215-23.